Trials / Completed
CompletedNCT03745885
A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
A Randomized, Double-blind, Placebo-controlled Study the Efficacy and Safety of Supaglutide in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the investigational drug Supaglutide proposed dosing once (or twice) weekly in Chinese healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Supaglutide injection | Administered SC in the Supaglutide arms. |
| DRUG | Placebo | Administered SC in the placebo arms and to maintain the blind in the Supaglutide injection arms. |
Timeline
- Start date
- 2018-12-04
- Primary completion
- 2019-06-10
- Completion
- 2019-12-13
- First posted
- 2018-11-19
- Last updated
- 2021-09-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03745885. Inclusion in this directory is not an endorsement.